- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05066217
EPX-100 (chlorhydrate de clémizole) comme traitement d'appoint chez les enfants atteints du syndrome de Lennox Gastaut
Un essai de preuve de concept multicentrique, randomisé, en double aveugle, contrôlé par placebo de 20 semaines sur EPX-100 (chlorhydrate de clémizole) en tant que traitement d'appoint chez les enfants atteints du syndrome de Lennox-Gastaut
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCl as adjunctive therapy in children and adult participants with LGS.
The study will consist of an Observational Period, a Double-Blind (DB) Period, and an optional Open-Label Extension (OLE) Period.
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Juby Philip
- Numéro de téléphone: (302) 559-4320
- E-mail: clinicaltrials@harmonybiosciences.com
Sauvegarde des contacts de l'étude
- Nom: Cindy Sandy
- Numéro de téléphone: (317) 258-7262
- E-mail: clinicaltrials@harmonybiosciences.com
Lieux d'étude
-
-
-
Beijing, Chine, 100045
- Recrutement
- Beijing Children's Hospital, Capital Medical University - PIN
-
Chercheur principal:
- Hui Xiong
-
Beijing, Chine, 100034
- Recrutement
- Peking University First Hospital - Changqiao Campus
-
Chercheur principal:
- Yuwu Jiang
-
Beijing, Chine, 100034
- Recrutement
- Peking University First Hospital - Daxing Campus
-
Chercheur principal:
- Yuwu Jiang
-
Changchun, Chine, 130021
- Recrutement
- The First Hospital of Jilin University
-
Chercheur principal:
- Jianmin Liang
-
Changsha, Chine, 410007
- Recrutement
- Hunan Children's Hospital
-
Chercheur principal:
- Sai Yang
-
Chengdu, Chine, 610041
- Recrutement
- West China Second University Hospital, Sichuan University - Huaxi Campus
-
Chercheur principal:
- Rong Luo
-
Chengdu, Chine, 610073
- Recrutement
- Chengdu Women's and Children's Central Hospital
-
Chercheur principal:
- Li Yan
-
Chongqing, Chine, 400014
- Recrutement
- Children's Hospital of Chongqing Medical University
-
Chercheur principal:
- Li Jiang
-
Guangzhou, Chine, 510260
- Recrutement
- The Second Affiliated Hospital of Guangzhou Medical University
-
Chercheur principal:
- Xiaorong Liu
-
Guiyang, Chine, 550004
- Recrutement
- The Affiliated Hospital of Guizhou Medical University
-
Chercheur principal:
- Rong Ai
-
Jinan, Chine, 250012
- Recrutement
- Qilu Hospital of Shandong University
-
Chercheur principal:
- Baomin Li
-
Nanchang, Chine, 330006
- Recrutement
- Jiangxi Provincial Children's Hospital
-
Chercheur principal:
- Yong Chen
-
Shenzhen, Chine, 518000
- Recrutement
- Shenzhen Children's Hospital
-
Chercheur principal:
- Dezhi Cao
-
Wuhan, Chine, 430015
- Recrutement
- Wuhan Children's Hospital
-
Chercheur principal:
- Dan Sun
-
Xi'an, Chine, 710004
- Recrutement
- The Second Affiliated Hospital of Xi'an Jiaotong University
-
Chercheur principal:
- Lin Yang
-
Xuzhou, Chine, 221006
- Recrutement
- Xuzhou Children's Hospital
-
Chercheur principal:
- Xiaoming Liu
-
-
Hunan
-
Changsha, Hunan, Chine, 410008
- Recrutement
- Xiangya Hospital Central South University
-
Chercheur principal:
- Jing Peng
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Chine, 200062
- Recrutement
- Children's Hospital of Shanghai
-
Chercheur principal:
- Simei Wang
-
-
-
-
-
Barcelona, Espagne, 08025
- Recrutement
- Hospital de La Santa Creu i Sant Pau
-
Chercheur principal:
- Alba Sierra-Marcos
-
Barcelona, Espagne, 08035
- Recrutement
- Hospital Universitario Vall d'Hebron - PPDS
-
Chercheur principal:
- Manuel Toledo Argany
-
Madrid, Espagne, 28009
- Recrutement
- Hospital Infantil Universitario Niño Jesus - PIN
-
Chercheur principal:
- Victor Soto Insuga
-
Málaga, Espagne, 29010
- Recrutement
- Hospital Regional Universitario de Malaga - Hospital General
-
Chercheur principal:
- Pedro Serrano
-
Pamplona, Espagne, 31008
- Recrutement
- Hospital Universitario de Navarra
-
Chercheur principal:
- Sergio Aguilera Albesa
-
Seville, Espagne, 41013
- Recrutement
- Centro de Neurologia Avanzada
-
Chercheur principal:
- Juan Jesús Rodríguez Uranga, MD
-
-
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Hongrie, 4032
- Recrutement
- Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus
-
Chercheur principal:
- Monika Bessenyei
-
-
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, Inde, 500082
- Recrutement
- Nizams Institute of Medical Sciences
-
Chercheur principal:
- Surya Prabha Turaga
-
Hyderabad, Andhra Pradesh, Inde, 500081
- Recrutement
- Yashoda Hospitals Hitec City
-
Chercheur principal:
- Lokesh Lingappa
-
-
Gujarat
-
Ahmedabad, Gujarat, Inde, 380054
- Recrutement
- Royal Institute of Child Neurosciences
-
Chercheur principal:
- Nitish Vora
-
Surat, Gujarat, Inde, 395002
- Recrutement
- Saachi Children Hospital
-
Chercheur principal:
- Ritesh Shah
-
-
Kerala
-
Calicut, Kerala, Inde, 673016
- Recrutement
- Aster Malabar Institute of Medical Sciences Ltd
-
Chercheur principal:
- Smilu Mohanlal
-
-
-
-
-
Catanzaro, Italie, 88100
- Recrutement
- Azienda Ospedaliera Universitaria Renato Dulbecco - AO Mater Domini
-
Chercheur principal:
- Antonio Gambardella
-
Florence, Italie, 50139
- Recrutement
- Azienda Ospedaliero Universitaria A Meyer
-
Chercheur principal:
- Renzo Guerrini
-
Milan, Italie, 20133
- Recrutement
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
Chercheur principal:
- Giuseppe Didato
-
Pavia, Italie, 27100
- Recrutement
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino IRCCS
-
Chercheur principal:
- Elena Tartara
-
-
Liguria
-
Genoa, Liguria, Italie, 16147
- Recrutement
- IRCCS Istituto Giannina Gaslini
-
Chercheur principal:
- Maria Margherita Mancardi
-
Genoa, Liguria, Italie, 16132
- Recrutement
- IRCCS Azienda Ospedaliera Metropolitan
-
Chercheur principal:
- Flavio Villani
-
-
Molise
-
Pozzilli, Molise, Italie, 86077
- Recrutement
- IRCCS Istituto Neurologico Mediterraneo Neuromed
-
Chercheur principal:
- Alfredo D'Aniello
-
-
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Pologne, 30-363
- Recrutement
- Centrum Medyczne Plejady Magdalena Celinska
-
Chercheur principal:
- Marta Zolnowska, MD
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Pologne, 50-414
- Recrutement
- Premium Clinic Wrocław Centrum Medyczne
-
Chercheur principal:
- Monika Sluzewska-Niedzwiedz
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Pologne, 02-829
- Recrutement
- Neurosphera
-
Chercheur principal:
- Beata Zwolinska
-
-
-
-
-
Bucharest, Roumanie, 050098
- Recrutement
- Emergency University Hospital
-
Chercheur principal:
- Ioana Raluca Mindruta
-
Bucharest, Roumanie, 041408
- Recrutement
- Centrul National Clinic De Recuperare Neuropsihomotorie Copii Robanescu-Padure
-
Chercheur principal:
- Madalina Leanca
-
Iași, Roumanie, 700309
- Recrutement
- Sf. Maria Children Emergency Clinical Hospital Iasi
-
Chercheur principal:
- Ioana Grigore
-
-
-
-
-
Belgrade, Serbie, 11000
- Recrutement
- Mother and Child Health Care Institute of Serbia Dr Vukan Cupic
-
Chercheur principal:
- Biljana Vucetic Tadic
-
Belgrade, Serbie, 11000
- Recrutement
- Childrens University Hospital
-
Chercheur principal:
- Dimitrije Nikolic
-
Niš, Serbie, 18 000
- Recrutement
- University Clinical Center Nis
-
Chercheur principal:
- Tatjana Tosic
-
Novi Sad, Serbie, 21000
- Recrutement
- Children and Youth Health Care Institute of Vojvodina
-
Chercheur principal:
- Tatjana Redzek Mudrinic
-
-
-
-
-
Ortahisar, Turquie (Türkiye), 61080
- Recrutement
- Karadeniz Teknik Universitesi Farabi Hastanesi
-
Chercheur principal:
- Ali Cansu
-
-
Eskişehir
-
Odunpazari, Eskişehir, Turquie (Türkiye), 26040
- Recrutement
- Eskisehir Osmangazi Universitesi Saglik Uygulama ve Arastirma Hastanesi
-
Chercheur principal:
- Kursat Carman
-
-
-
-
Arkansas
-
Little Rock, Arkansas, États-Unis, 72202
- Actif, ne recrute pas
- Arkansas Children's Hospital
-
-
California
-
Orange, California, États-Unis, 92868
- Actif, ne recrute pas
- UC Irvine Medical Center
-
-
Florida
-
Miami, Florida, États-Unis, 33136
- Recrutement
- University of Miami Miller School of Medicine
-
Contact:
- Brett Alonso Cardenas
- Numéro de téléphone: 305-243-3100
- E-mail: bac301@med.miami.edu
-
Chercheur principal:
- Kamil Detyniecki, MD
-
Orlando, Florida, États-Unis, 32804
- Recrutement
- AdventHealth Innovation Tower
-
Chercheur principal:
- Holly Skinner, DO
-
Orlando, Florida, États-Unis, 34746
- Suspendu
- Rare Disease Research
-
Winter Park, Florida, États-Unis, 32789
- Actif, ne recrute pas
- Pediatric Neurology and Epilepsy Specialists
-
-
Illinois
-
Chicago, Illinois, États-Unis, 60611
- Recrutement
- Re:Cognition Health
-
Contact:
- Antonio Iglesias, MD
- Numéro de téléphone: 312-971-3318
- E-mail: aiglesias@re-cognitionhealth.com
-
Chercheur principal:
- Antonio Iglesias, MD
-
-
Kentucky
-
Louisville, Kentucky, États-Unis, 40202
- Recrutement
- Norton Children's Medical Center
-
Chercheur principal:
- Jaime Shoup, MD
-
Contact:
- Madeline McGinty-Holmes
- Numéro de téléphone: 502-629-5568
- E-mail: madeline.mcginty-holmes@louisville.edu
-
-
Michigan
-
Detroit, Michigan, États-Unis, 48202
- Actif, ne recrute pas
- Henry Ford Hospital
-
-
Minnesota
-
Roseville, Minnesota, États-Unis, 55102
- Recrutement
- Minnesota Epilepsy Group, P.A.
-
Contact:
- Sarah Ellis, MD
- Numéro de téléphone: 651-377-8319
- E-mail: sellis@mnepilepsy.net
-
Chercheur principal:
- Stephanie Ahrens, MD
-
-
Nebraska
-
Omaha, Nebraska, États-Unis, 68114
- Recrutement
- Children's Nebraska
-
Contact:
- Sookyong Koh, MD, PhD
- Numéro de téléphone: 773-929-4445
- E-mail: skoh@childrensnebraska.org
-
Chercheur principal:
- Sookyong Koh
-
-
New Jersey
-
Marlboro, New Jersey, États-Unis, 07746
- Recrutement
- Tekton Research
-
Chercheur principal:
- Amor Mehta, MD
-
Contact:
- Aimee Kinlan
- Numéro de téléphone: 626-218-8294
- E-mail: aimee.kinlan@tektonresearch.com
-
-
New York
-
New York, New York, États-Unis, 10021
- Recrutement
- Weill Cornell Medicine/New York Presbyterian Hospital
-
Contact:
- Lundy Santil
- Numéro de téléphone: Ext. 198 800-785-3150
- E-mail: ludny.saintil@thermofisher.com
-
Contact:
- Asim Shahid
- E-mail: los9075@med.cornell.edu
-
Chercheur principal:
- Asim Shahid, MD
-
New York, New York, États-Unis, 10016-4852
- Recrutement
- NYU Comprehensive Epilepsy Center - BRANY - PPDS
-
Chercheur principal:
- Dana Price
-
-
North Carolina
-
Charlotte, North Carolina, États-Unis, 28211
- Recrutement
- On-Site Clinical Solution
-
Chercheur principal:
- Robert Nahouraii
-
Contact:
- Ludny Saintil
- Numéro de téléphone: 198 800-785-3150
- E-mail: ludny.santil@thermofischer.com
-
Charlotte, North Carolina, États-Unis, 28207
- Recrutement
- Atrium Health STRIVE Research
-
Contact:
- Jessica Lindley
- E-mail: Jessica.Lindley@atriumhealth.org
-
Chercheur principal:
- Ravi Singh, MD
-
Durham, North Carolina, États-Unis, 27705
- Recrutement
- Duke University Medical Center
-
Contact:
- Muhammad Zafar, MD
- E-mail: muhammad.zafar@duke.edu
-
Chercheur principal:
- Muhammad Zafar, MD
-
Morrisville, North Carolina, États-Unis, 27560
- Recrutement
- PPD Virtual-Science 37, Inc.
-
Chercheur principal:
- Antonio Iglesias, MD
-
Contact:
- Victoria Taylor
- Numéro de téléphone: 615-707-9148
- E-mail: victoria.taylor@science37.com
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Recrutement
- Children's Hospital of Philadelphia
-
Chercheur principal:
- Eric Marsh, MD
-
-
Texas
-
Dallas, Texas, États-Unis, 75235
- Recrutement
- Children's Health Specialty Center
-
Chercheur principal:
- Charuta Joshi
-
Houston, Texas, États-Unis, 77030
- Recrutement
- UTHealth Houston
-
Contact:
- Antoinette Bernal-Tent
- Numéro de téléphone: 713-500-7105
- E-mail: Antoinette.BernalTent@uth.tmc.edu
-
Chercheur principal:
- Mary Koenig, MD
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84132
- Recrutement
- Clinical Neurosciences Center
-
Chercheur principal:
- Angela Peters, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Key Inclusion Criteria:
-
Males or females, ages ≥2 to ≤55 years, at the time of Screening.
-
Participant/parent/legal authorized representative (LAR) willing and able to give written informed consent/assent.
-
Diagnosis of LGS, including:
- Evidence of at least one type of countable major motor seizure.
- History of electroencephalogram (EEG) consistent with LGS (abnormal background activity, and one of the following: 1) slow spike-wave discharges [<2.5 Hz], or 2) paroxysmal fast activity during sleep).
- Abnormal cognitive development.
- Onset of seizures at 11 years of age or younger.
Key Exclusion Criteria:
- Known sensitivity, allergy, or previous exposure to clemizole HCl.
- Known history of long QT syndrome or any significant history of a serious abnormality of the electrocardiogram (ECG) (e.g., recent myocardial infarction, clinically significant arrhythmia).
- Family history of sudden cardiac death, unexplained death, or death from a primary dysrhythmia potentially associated with QT prolongation in any family member.
- Seizures secondary to illicit drug or alcohol use, infection, neoplasm, demyelinating disease, degenerative neurological disease, or progressive central nervous system disease, metabolic illness, recent anoxic episode within the last 6 months requiring resuscitation, or progressive degenerative disease or any other condition, which in the opinion of the investigator, could affect seizure control.
- Epilepsy surgery planned during the study or epilepsy surgery within 6 months prior to Screening.
- Concomitant use of fenfluramine.
- Prior or concomitant use of lorcaserin.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: Placebo
Participants will receive their first dose of study drug following randomization. |
Placebo will be administered as an oral solution. |
|
Expérimental: Double-blind clemizole HCl
Participants will receive their first dose of study drug following randomization. |
Clemizole HCl will be administered as an oral solution.
Autres noms:
|
|
Expérimental: Open-label clemizole HCl
Eligible participants who complete the DB Period will have the option to continue in the OLE Period, during which they will receive clemizole HCl for up to 3 years. |
Clemizole HCl will be administered as an oral solution.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Percent Change in CMMS-28
Délai: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Délai: From Baseline Period up to 16 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28 Seizure-free Days
Délai: From Baseline Period up to 16 weeks
|
Percent change in CMMS-28 seizure-free days from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Clinical Global Impression of Change (CGI-C) Score
Délai: Week 16
|
CGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change (CaGI-C) Score
Délai: Week 16
|
CaGI-C score at the end of the DB Period |
Week 16
|
|
Caregiver Global Impression of Change in Seizure Intensity/Duration (CaGI-CSID) Score
Délai: Week 16
|
CaGI-CSID score at the end of the DB Period |
Week 16
|
|
Change in Quality of Life Inventory (QI)-Disability Score
Délai: From Baseline Period up to 16 weeks
|
Change in QI-disability score from Baseline to the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change per 28 Days in the Number of Seizure Free Days
Délai: From Baseline Period up to 16 weeks
|
Percent change per 28 days in the number of seizure-free days (based on all seizure types) from the Baseline Period through the end of the DB Period |
From Baseline Period up to 16 weeks
|
|
Percent Change in CMMS-28
Délai: From Baseline Period up to 12 weeks
|
Percent change in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Proportion of Participants with ≥50% Reduction in CMMS-28
Délai: From Baseline Period up to 12 weeks
|
Proportion of participants with ≥50% reduction in CMMS-28 from the Baseline Period through the end of the DB Maintenance Phase only |
From Baseline Period up to 12 weeks
|
|
Incidence of Treatment-Emergent Adverse Events (TEAEs)
Délai: From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Incidence of TEAEs will be compared among the treatment groups |
From the first dose administration of study drug up to end of the study, approximately up to 172 weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Directeur d'études: Amit Ray, MD, Harmony Biosciences Management, Inc.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Syndromes épileptiques
- Manifestations neurologiques
- Maladies du cerveau
- Maladies du système nerveux central
- Maladies du système nerveux
- Maladies génétiques, innées
- Épilepsie
- Maladies et anomalies congénitales, héréditaires et néonatales
- Conditions pathologiques, signes et symptômes
- Signes et symptômes
- Saisies
- Syndrome de Lennox Gastaut
Autres numéros d'identification d'étude
- EPX-100-003
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .